Latest P53 Stories
SAN ANTONIO, Feb. 28, 2011 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD) today announced the results of its clinical study utilizing RNAscope(TM) technology to detect human papillomavirus (HPV) E6/E7 mRNA in routine clinical specimens of head and neck cancer.
Like a bounty hunter returning escapees to custody, a cancer-fighting gene converts organ cells that change into highly mobile stem cells back to their original, stationary state.
Chemotherapeutic agents, used in cancer treatment, destroy not only cancer cells but also healthy cells, thus affecting germ cells as well.
To protect the health of future generations, body keeps a careful watch on its precious and limited supply of eggs.
One of the most important genes in the human genome is called p53 and its function is to suppress tumors.
A constellation of different stem cell populations within our skin help it to cope with normal wear and tear.
For several decades, researchers have been linking genetic mutations to diseases ranging from cancer to developmental abnormalities.
Scientists are reporting discovery of a potential biochemical basis for the apparent cancer-fighting ability of broccoli and its veggie cousins.
A study shows for the first time that the three most common chromosome changes seen in chronic lymphocytic leukemia disrupt a molecular network that includes several important genes and strongly influences the outcome of the disease.
Researchers from the Kimmel Cancer Center at Jefferson and two other institutions have discovered new evidence that suggests the "longevity" protein SIRT1, known for its life-spanning effects in different species, can inhibit the development of a known precursor to prostate cancer, prostatic intraepithelial neoplasia (PIN).